- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/705 - RécepteursAntigènes de surface cellulaireDéterminants de surface cellulaire
Détention brevets de la classe C07K 14/705
Brevets de cette classe: 15229
Historique des publications depuis 10 ans
|
758
|
943
|
1061
|
1103
|
1300
|
1270
|
1205
|
1193
|
1067
|
99
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 20355 |
326 |
| The Trustees of the University of Pennsylvania | 4382 |
324 |
| The Board of Trustees of the Leland Stanford Junior University | 6594 |
211 |
| Memorial Sloan-Kettering Cancer Center | 1985 |
194 |
| Regeneron Pharmaceuticals, Inc. | 4505 |
192 |
| Board of Regents, The University of Texas System | 5989 |
166 |
| Immatics Biotechnologies GmbH | 1137 |
149 |
| Novartis AG | 10494 |
145 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2942 |
134 |
| The General Hospital Corporation | 4793 |
93 |
| Dana-Farber Cancer Institute, Inc. | 2640 |
87 |
| Autolus Limited | 264 |
85 |
| City of Hope | 1008 |
79 |
| CRISPR Therapeutics AG | 376 |
78 |
| Alpine Immune Sciences, Inc. | 79 |
74 |
| Baylor College of Medicine | 983 |
74 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 997 |
73 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3355 |
73 |
| The Johns Hopkins University | 5772 |
68 |
| Lentigen Technology, Inc. | 104 |
68 |
| Autres propriétaires | 12536 |